InspireMD, Inc. — Director's Dealing 2016

Jul 11, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2016-07-07

Reporting Person: Stuka Paul (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-07	Series B Convertible Preferred Stock	$0.33	P	3030	Acquired	2021-07-07	Common Stock (530250)	Direct
2016-07-07	Warrants to Purchase Common Stock	$0.20	P	303000	Acquired	2021-07-07	Common Stock (303000)	Direct
2016-07-07	Series B Convertible Preferred Stock	$0.33	P	1515	Acquired	2021-07-07	Common Stock (265125)	Indirect
2016-07-07	Warrants to Purchase Common Stock	$0.20	P	151500	Acquired	2021-07-07	Common Stock (151500)	Indirect

Footnotes

F1: Consists of 303,000 shares of Common Stock issuable upon conversion of the Preferred Stock at the conversion price of $0.33 per share and the stated value of $33 and payment of all dividends accrued on the Preferred Stock in an aggregate of 227,250 shares of Common Stock upon conversion of the Preferred Stock.

F2: Each share of Preferred Stock was accompanied by a Warrant to purchase 100 shares of Common Stock at an exercise price of $0.20 per share of Common Stock. Each share of Preferred Stock and accompanying Warrant to Purchase Common Stock was acquired at an aggregate price of $33.00.

F3: Consists of 151,500 shares of Common Stock issuable upon conversion of the Preferred Stock at the conversion price of $0.33 per share and the stated value of $33 and payment of all dividends accrued on the Preferred Stock in an aggregate of 113,625 shares of Common Stock upon conversion of the Preferred Stock.

F4: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes.